Viewing Study NCT05107193


Ignite Creation Date: 2025-12-25 @ 1:05 AM
Ignite Modification Date: 2025-12-25 @ 11:17 PM
Study NCT ID: NCT05107193
Status: NO_LONGER_AVAILABLE
Last Update Posted: 2022-11-08
First Post: 2021-09-16
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Afatinib (GILOTRIF®) in Patients Suffering From Tumors Harboring Neuregulin 1 (NRG1) Gene Alterations (Specifically NRG1 Gene Fusion-positive Advanced Solid Tumors)
Sponsor: Boehringer Ingelheim
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module References Module